The House Committee on Insurance meeting covered multiple bills focused on healthcare regulations and patient accessibility. Notably, House Bill 3057 was highlighted in testimony from citizens advocating for expanded access to CAR T-cell therapy, which has shown effectiveness for blood cancers. Testimonies were given by affected individuals, emphasizing the need for local treatment options without the burden of travel to distant medical facilities. Similarly, House Bill 4603 was laid out with the intent to align arbitration options and ensure that consumers receive timely resolutions in disputed medical charges. Overall, the committee demonstrated an active engagement with the public and various stakeholders while navigating key issues affecting health insurance and patient care in Texas.
Relating to the authority of the Texas Department of Insurance to adopt rules that implement or are based on certain environmental, social, and governance models, ratings, or standards.
Relating to claims payments to health care providers by health maintenance organizations, preferred provider benefit plans, or managed care organizations.
Relating to the health benefit plan coverage of and reimbursement for the treatment of a first responder's injuries sustained within the course and scope of employment.